香港股市 已收市

TXN Oct 2024 120.000 put

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
0.30000.0000 (0.00%)
市場開市。 截至 09:37AM EDT。
全螢幕
前收市價0.3000
開市0.3000
買盤0.0000
賣出價0.0000
拍板120.00
到期日2024-10-18
今日波幅0.3000 - 0.3000
合同範圍
成交量1
未平倉合約
  • Bloomberg

    Elliott Bets $2.5 Billion on Shaking Up Texas Instruments

    (Bloomberg) -- Elliott Investment Management has invested more than $2.5 billion in Texas Instruments Inc. and is pushing the chipmaker to improve free cash flow, setting the stage for another campaign by the influential activist investor.Most Read from BloombergWall Street Returns to T+1 Stock Trading After a CenturyTreasuries Hit as US Sales Struggle to Lure Buyers: Markets WrapFor Private Credit’s Top Talent, $1 Million a Year Is Not EnoughWorld’s Largest Nuclear Plant Sits Idle While Energy

  • Barrons.com

    Texas Instruments Gets an Activist Investor. Free Cash Flow Is the Target.

    News that the activist investor Elliott Investment Management is pushing for a big boost to free cash flow at Texas Instruments sent the semiconductor stock higher on Tuesday. Elliott published a 13-page letter to Texas Instrument’s board on Tuesday, disclosing that it has a stake of more than $2.5 billion in the company. “TI’s shareholder returns have lagged peers consistently over a multi-year period, despite TI’s reputation as one of the best-managed semiconductor companies with strong growth prospects and competitive advantages,” Elliott wrote in the letter.

  • Reuters

    Activist investor Elliott discloses $2.5 billion stake in Texas Instruments

    Elliott proposed in a letter to the company's board that Texas Instruments introduce a "dynamic capacity-management strategy", which would allow it to achieve free cash flow of as much as $9 a share by 2026. The company's free cash flow fell 77% to $1.47 per share in 2023, according to LSEG data. In a report earlier this year, Texas Instruments said it expects capital spending of about $5 billion a year through 2026 and projected capital expenditure of 10% to 15% of revenue in 2027 and beyond.